Immediate Impact

43 standout
Sub-graph 1 of 19

Citing Papers

RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
2 intermediate papers

Works of Laura Rizzà being referenced

Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors
2018
Everolimus is a new anti-cancer molecule: Metabolic side effects as lipid disorders and hyperglycemia
2018

Author Peers

Author Last Decade Papers Cites
Laura Rizzà 66 100 32 90 90 11 240
Emma Scott 45 112 28 109 63 11 298
David E. Kardon 195 24 16 124 82 13 286
Michel Polak 79 160 51 25 25 11 267
Li Yin Ooi 31 39 29 54 26 14 259
Ángel Castaño 36 26 95 130 95 12 266
Hidetaka Fujinaga 111 71 28 62 159 12 233
Huan Liu 42 27 106 27 55 13 287
Michele Fabrizio 43 83 23 18 23 13 228
Kangli Qiu 23 115 31 17 41 13 277
Marieme Dembele 34 87 29 21 23 10 281

All Works

Loading papers...

Rankless by CCL
2026